Stay updated on Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.

Latest updates to the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision history now shows the latest published revision as v3.6.3, replacing the previous v3.6.2, indicating a minor update to the page's published revision.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page history shows a newer revision entry (v3.6.2) replacing the previous v3.6.0, indicating a minor update to the page's revision record.SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history now includes a recruitment status update indicating no further participant enrollment, and a new revision entry (v3.6.0) alongside the removal of a previous revision (v3.5.5).SummaryDifference0.2%

- Check40 days agoChange DetectedA new Revision: v3.5.5 entry was added to the history and the previous Revision: v3.5.4 was removed, updating the page's version history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study record gains updated Study Status and Contacts/Locations sections. These changes reflect the current status and contact details for the trial.SummaryDifference0.3%

- Check61 days agoChange DetectedA new revision entry, Revision: v3.5.4, is added to the Record History, replacing Revision: v3.5.3. This entry reflects an update to the record's version history.SummaryDifference0.1%

Stay in the know with updates to Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.